Ankebin

Ankebin Brand names, Ankebin Analogs

Ankebin Brand Names Mixture

No information avaliable

Ankebin Chemical_Formula

C₂₀H₂₁ClO₄

Ankebin RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Ankebin fda sheet

Ankebin FDA

Ankebin msds (material safety sheet)

Ankebin MSDS

Ankebin Synthesis Reference

No information avaliable

Ankebin Molecular Weight

360.831 g/mol

Ankebin Melting Point

80.5 °C

Ankebin H₂O Solubility

0.25mg/ml at 25 °C

Ankebin State

Solid

Ankebin LogP

5.575

Ankebin Dosage Forms

Capsule; Tablet

Ankebin Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Ankebin Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Ankebin Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Ankebin side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Ankebin Patient Information